ERIS Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
713.25
731.67
745.72
721.36
566.07
Other Income Qtr Cr7.954.226.771.6415.15
Operating Revenues Qtr705.30727.45738.95719.72550.92

*All values are in Cr.

Operating Expenses Qtr
452.91
477.14
476.66
469.73
402.49
Operating Profit Qtr
252.39
250.31
262.29
249.99
148.43
EBITDA Qtr Cr
260.34
254.53
269.06
251.63
163.58
Depreciation Qtr
77.25
81.20
80.48
75.94
53.90
Net Profit Qtr
93.84
83.63
91.59
83.18
70.96
Basic EPS Qtr
6.90
6.15
6.73
6.11
5.22
Open Demat Account
+91 -

Open Demat Account
+91 -